Danco Asks Supreme Court To Restore Mail Access To Mifepristone
Danco Laboratories asked the Supreme Court on Saturday to stay a Friday 5th Circuit order that halted telehealth and mail distribution of mifepristone nationwide.
RedStateWith 5th Circuit's Temporary Block of Abortion Pill by Mail, Louisiana v. FDA Might Get SCOTUS Review
Daily CallerAbortion Pill Case Heads To Supreme Court
ABC NewsThe Supreme Court is being asked to restore access to an abortion pill by mail. Here's what to know
Straight Arrow NewsSupreme Court asked to block ruling restricting remote access to abortion pill
Overview
Danco Laboratories asked the Supreme Court on Saturday to block a Friday 5th U.S. Circuit Court of Appeals ruling that reinstated an in-person dispensing requirement for mifepristone.
The appeals court's Friday order temporarily overturned 2023 FDA guidance allowing telehealth and mail distribution of mifepristone and reinstated in-person dispensing while litigation proceeds.
Danco's emergency filing said the appeals ruling "injects immediate confusion and upheaval" and urged the justices to issue a stay and take the case on the merits.
The order takes effect nationwide and could curb access to mifepristone, which sources say is used in roughly two out of every three abortions and that medication abortions make up more than half of U.S. abortions.
The case stems from Louisiana's challenge and is expected to proceed through appeals, with Danco and other makers asking the Supreme Court to pause the 5th Circuit's order as litigation continues.
Analysis
Center-leaning sources report this case neutrally, prioritizing legal and factual context over partisan rhetoric. They summarize court orders and FDA history, cite statements from both Louisiana officials and abortion-rights groups, and include medical data from FDA and ACOG. Editorial language stays descriptive; charged claims appear as attributed quotes from named sources.